FDA Approved: MONTELUKAST — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application from Sandoz Inc for montelukast under the ANDA, confirming changes to the generic product's labeling. The drug is used t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Exercise-induced Bronchoconstriction

Drugs mentioned

• Montelukast (Montelukast)

Snippet

SUPPL AP for MONTELUKAST (MONTELUKAST)